Edwards Lifesciences Performance

Edwards Lifesciences Corporation -- USA Stock  

USD 137.16  0.14  0.10%

Edwards Lifesciences has performance score of 6 on a scale of 0 to 100. The firm shows Beta (market volatility) of -0.2383 which denotes to the fact that as returns on market increase, returns on owning Edwards Lifesciences are expected to decrease at a much smaller rate. During bear market, Edwards Lifesciences is likely to outperform the market.. Although it is extremely important to respect Edwards Lifesciences historical returns, it is better to be realistic regarding the information on equity current trending patterns. The philosophy towards predicting future performance of any stock is to evaluate the business as a whole together with its past performance including all available fundamental and technical indicators. By reviewing Edwards Lifesciences technical indicators you can presently evaluate if the expected return of 0.1026% will be sustainable into the future. Edwards Lifesciences right now shows a risk of 1.0134%. Please confirm Edwards Lifesciences Potential Upside as well as the relationship between Kurtosis and Day Typical Price to decide if Edwards Lifesciences will be following its price patterns.
 Time Horizon     30 Days    Login   to change

Edwards Lifesciences Relative Risk vs. Return Landscape

If you would invest  13,425  in Edwards Lifesciences Corporation on February 21, 2018 and sell it today you would earn a total of  305.00  from holding Edwards Lifesciences Corporation or generate 2.27% return on investment over 30 days. Edwards Lifesciences Corporation is generating 0.1026% of daily returns and assumes 1.0134% volatility on return distribution over the 30 days horizon. Put differently, 9% of equity instruments are less risky than the company on the bases of their historical return distribution and some 99% of equities are expected to be superior in generating returns on investments over the next 30 days.
 Daily Expected Return (%) 
      Risk (%) 
Allowing for the 30-days total investment horizon, Edwards Lifesciences Corporation is expected to generate 1.09 times more return on investment than the market. However, the company is 1.09 times more volatile than its market benchmark. It trades about 0.1 of its potential returns per unit of risk. The DOW is currently generating roughly -0.02 per unit of risk.

Operating Margin

Edwards Lifesciences Operating Margin
Based on recorded statements Edwards Lifesciences Corporation has Operating Margin of 29.8%. This is 190.61% lower than that of the Healthcare sector, and significantly higher than that of Healthcare Products industry, The Operating Margin for all stocks is 373.14% lower than the firm.
A good Operating Margin is required for a company to be able to pay for its fixed costs or pay out its debt which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against firm's competitors.

Edwards Lifesciences Daily Price Distribution

The median price of Edwards Lifesciences for the period between Wed, Feb 21, 2018 and Fri, Mar 23, 2018 is 137.85 with a coefficient of variation of 2.07. The daily time series for the period is distributed with a sample standard deviation of 2.85, arithmetic mean of 137.66, and mean deviation of 2.4. The Stock received some media coverage during the period.

Risk-Adjusted Performance

Compared to the overall equity markets, risk-adjusted returns on investments in Edwards Lifesciences Corporation are ranked lower than 6 (%) of all global equities and portfolios over the last 30 days.

One Month Efficiency

Edwards Lifesciences Sharpe Ratio = 0.1013
Good Returns
Average Returns
Small Returns
Negative Returns

Estimated Market Risk

  actual daily
 91 %
of total potential

Expected Return

  actual daily
 1 %
of total potential

Risk-Adjusted Return

  actual daily
 6 %
of total potential
Based on monthly moving average Edwards Lifesciences is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Edwards Lifesciences by adding it to a well-diversified portfolio.